Yael Cohen
TASMC · Tel-Aviv Sourasky Medical Center · Prilenia
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Yael Cohen as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 00:02 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT04813653 · Cyclosporine in Combination With Carfilzomib and Dexamethasone in Relapsed Multiple Myeloma Refractory to Carfilzomib and High Expression of PPIA Gene in Myeloma CellsTel-Aviv Sourasky Medical Center · completed · Multiple Myeloma in Relapse, Multiple Myeloma, Refractory · principal investigator
- Ph2NCT04790474 · Ixazomib-pomalidomide-dexamethasone as Second or Third-line Combination Treatment for Patients With Relapsed and Refractory Multiple Myeloma Previously Treated With Daratumumab, Lenalidomide and BortezomibTel-Aviv Sourasky Medical Center · active not recruiting · Multiple Myeloma in Relapse, Refractory Multiple Myeloma · principal investigator
- Ph3NCT04556656 · PRidopidine's Outcome On Function in Huntington Disease, PROOF- HDPrilenia · completed · Huntington Disease · study director
- Ph2NCT04065789 · Carfilzomib in Combination With Daratumumab, Lenalidomide and Dexamethasone in Transplant-ineligible NDMM PatientsTel-Aviv Sourasky Medical Center · completed · Myeloma Multiple, Myeloma, Plasma-Cell, Myeloma-Multiple · principal investigator
- Ph2NCT03922711 · A Study to Assess the Safety and Effectiveness of Pridopidine Compared to Placebo in the Treatment of Levodopa-Induced Dyskinesia in Patients With Parkinson's DiseasePrilenia · terminated · Parkinson Disease · study director
- Ph2NCT00696943 · 18F ML-10 for Early Detection of Response of Brain Metastases to SRSAposense Ltd. · terminated · Metastasis to Brain of Unknown Primary · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 00:02 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 00:02 UTC. The ranking covers the 200 most relevant of 98 PubMed records, and a shared surname and initials can bring in a namesake. All 98 on PubMed
- 2,110 citationsRCR 56.5
- Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome.N Engl J Med · 20181,714 citationsRCR 84.9
- 1,237 citationsRCR 52.6
- 887 citationsRCR 36.6
- Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma.N Engl J Med · 2023749 citationsRCR 61.8
- 473 citationsRCR 15.6
- 433 citationsRCR 13.9
- HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption.Nature · 2016429 citationsRCR 13.0
- Personalized microbiome-driven effects of non-nutritive sweeteners on human glucose tolerance.Cell · 2022320 citationsRCR 25.9
- 313 citationsRCR 14.3